Glenmark

Glenmark Pharma gets ANDA approval for diltiazem hydrochloride ER capsules

Read more

Glenmark Pharma and Menarini enter into exclusive licensing agreement for commercialising Ryaltris for European markets

Read more

Glenmark launches NINDANIB (nintedanib) for pulmonary fibrosis in India

Read more

SEC asks CDSCO to submit adverse event report of death during Umifenovir trial

Read more

Glenmark Pharmaceuticals gets ANDA approval for multiple sclerosis drug

Read more

HEAL Foundation organises Pharma Excellence Awards 2020

Read more

Remdesivir and favipiravir price regulation required to safeguard patients’ interest in India: GlobalData

Read more

Glenmark announces top-line results from Phase 3 clinical trial of favipiravir for COVID-19 treatment

Read more

FabiFlu more affordable than other drugs: Glenmark to DCGI

Read more

Glenmark set to get manufacturing and marketing approval for favipiravir

Read more